8 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications Summary ... Table Insulin ... GLP-1 receptor agonists ... Improved outcomes in CKD ... endocrinology #dm2
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... #Pharmacology #Dosing ... #Dosing #Renal ... #Impairment #CKD ... #Table #GFR #Hypoglycemics
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology Summary ... Ozempic), or daily tablet ... #Pharmacology #Summary ... #DM2 #diabetes
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... Januvia) - Once/day tablet ... GLP-I receptor agonist ... #Pharmacology #Summary ... #DM2 #diabetes
NSAID Dosing in CKD
 • Carboxylic Acids: Salsalate, Choline Mg trisalicylate
 • Acetic Acids: Indomethacin, Tolmetin,
NSAID Dosing in ... CKD • Carboxylic ... trisalicylate • Acetic ... #CKD #pharmacology ... #table
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
Summary of actions ... some Cholinergic Agonists ... Produces miosis during ... #Pharmacology #Table ... #Summary
Acromegaly - Diagnosis and Management Summary - GrepMed Handbook 

Clinical Presentation: 
 • Classic Acromegaly: frontal
and Management Summary ... Acromegaly: frontal bossing ... Mortality due to CVD ... Pegvisomant) ± D2 ... agonist (Carbergoline
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Cardiomyopathy - Summary ... Management during ... Management during ... Delivery • Stable ... Bromocriptine, a dopamine agonist